In 2016, the USPTO launched the Patents 4 Patients program to support the $1 billion National Cancer Moonshot initiative. In September of this year, the USPTO announced that the pilot program would be extended through January 31, 2023.
The United States Patent and Trademark Office (USPTO) and the World Intellectual Property Association (WIPO) have announced a partnership to facilitate the resolution of disputes related to standard essential patents (SEPs).
We are nearing the halfway point of 2022, with a new director at the USPTO, another opportunity to clarify the §101 patent eligibility framework, and a pair of bills poised to innovate the semiconductor industry. Here’s what you need to know about the year in patents so far.
COVID may have affected in-person attendance at this year's Consumer Electronics Show (CES), but it didn't diminish the innovation on display. CES still reflects the future of consumer culture and technology.
The year was defined by an ongoing pandemic, the inauguration of a new president, and a generally shaky economy. Fortunately, the IP industry has continued to grow and adjust and prepare for a future that is hard to predict.